Pre-Market Stock Movements: Spotlight on Intapp's Decline Following Analyst Downgrade
Jul 9, 2024
ADCT Equities
ADC Therapeutics Awards Stock Options to New Employees as Part of Inducement Plan
Jun 3, 2024
ADC Therapeutics SA Joins H.C. Wainwright BioConnect Investor Conference
May 16, 2024
Anticipating Decline: ADC Therapeutics SA ADCT Braces for Q4 Earnings Release
Feb 20, 2024
ADC Therapeutics Reports Promising Outcomes from ZYNLONTA® and Rituximab Combo Therapy in a Phase 2 Trial for Follicular Lymphoma
Dec 13, 2023